Kategori: Publikationer

The usefulness of the Simplified Erosion Narrowing Score (SENS) in clinical practice for estimating joint damage in early rheumatoid arthritis.

Forslind K; BARFOT Study Group. Scand J Rheumatol. 2011 Nov;40(6):497-8.

High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis.

Isgren A, Forslind K, Erlandsson M, Axelsson C, Andersson S, Lund A, Bokarewa M. Semin Arthritis Rheum. 2012 Apr;41(5):652-7.

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF. Ann Rheum Dis. 2012 Feb;71(2):186-91.

Long-term in-vitro precision of direct digital X-ray radiogrammetry.

Dhainaut A, Hoff M, Kälvesten J, Lydersen S, Forslind K, Haugeberg G. Skeletal Radiol. 2011 Dec;40(12):1575-9.

The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.

Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF. Scand J Rheumatol. 2011 Mar;40(2):81-7.

Joint destruction in early rheumatoid arthritis over 8 years is similar in women and men despite apparently higher disease activity and poorer function in women.

Hafström I, Bala V, Albertsson K, Forslind K, Svensson B; BARFOT study group. Ann Rheum Dis. 2011 Apr;70(4):709-10.

Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis.

Svensson B, Hafström I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M. Ann Med. 2010;42(1):45-54.

Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.

Forslind K, Boonen A, Albertsson K, Hafström I, Svensson B; Barfot Study Group. Scand J Rheumatol. 2009 Nov-Dec;38(6):431-8.

Self-reported outcomes during treatment with tumour necrosis factor alpha inhibitors in patients with rheumatoid arthritis.

Bala SV, Forslind K, Månsson ME. Musculoskeletal Care. 2010 Mar;8(1):27-35.

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J. Lancet. 2009 Aug 8;374(9688):459-66.